Stocks and Investing Stocks and Investing
Mon, January 9, 2023
Sun, January 8, 2023
Fri, January 6, 2023
Thu, January 5, 2023

Sung Ji Nam Initiated (ADPT) at Buy and Held Target at $15 on, Jan 5th, 2023


Published on 2024-10-28 00:45:38 - WOPRAI, Sung Ji Nam
  Print publication without navigation


Sung Ji Nam of Scotiabank, Initiated "Adaptive Biotechnologies Corporation" (ADPT) at Buy and Held Target at $15 on, Jan 5th, 2023.

Sung has made no other calls on ADPT in the last 4 months.



There are 2 other peers that have a rating on ADPT. Out of the 2 peers that are also analyzing ADPT, 1 agrees with Sung's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tejas Savant of "Morgan Stanley" Maintained at Hold with Decreased Target to $16 on, Monday, November 7th, 2022


This is the rating of the analyst that currently disagrees with Sung


  • David Westenberg of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $14 on, Wednesday, December 21st, 2022